Dr Vk Paul

Four cases of monkeypox have been reported in India but there is absolutely no need for any panic as the government has taken significant measures to keep the disease in check, said Niti Aayog member Dr VK Paul.

Dr VK Paul, Member-Health, Niti Aayog on Thursday said that the overall COVID-19 situation in the country is optimistic, however, India cannot lower its guard.

There will be no mix-and-match of vaccines for those eligible to get a 'precautionary' third dose, Dr VK Paul, the head of India's Covid task force, said Wednesday, meaning those who got Covishield will get the same, as will those who got Covaxin.

The requirement, timing and nature of COVID vaccine booster doses will be based on scientific decisions according to Dr VK Paul, Member-Health, Niti Aayog, today.

Amid concerns over the Omicron variant of coronavirus, Covid Task Force chief Dr VK Paul on Tuesday said India should have vaccine platforms that are "adaptable quickly" with changing nature of the variants.

The Centres priority is to fully vaccinate the adult population of the country against coronavirus, NITI Aayogs Member-Health Dr VK Paul said as the new variant Omicron has triggered a global alarm with several countries imposing fresh curbs.

The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.

The World Health Organisation's approval for emergency use of Covaxin can come before the end of the month, Dr VK Paul, chairman of the National Expert Committee on Vaccine Administration, told reporters today.

Dr VK Paul, the NITI Aayog Member for Health, said battling Covid will require a combination of vaccines, effective drugs, and disciplined social behaviour. He did not ruling out a third wave and cautioned against the risky festival lying ahead.

The national expert committee on COVID-19 vaccination has discussed the issue of giving booster vaccine dose and it is being looked into very deeply, NITI Aayog Member (Health) Dr VK Paul said on Tuesday.

Serosurveys cannot be extrapolated to estimate mortality rates of COVID-19 or undercounting of the number of coronavirus infections as they are not meant to cover granularity at the level of the state, NITI Aayog member (health) Dr VK Paul has said.

The Government of India is holding discussions with COVID-19 manufacturers Moderna and Pfizer over several issues including indemnity waiver, Dr VK Paul, Member (Health), NITI Aayog said on Friday.

Drugs Controller General of India (DCGI) is examining pharmaceutical major Zydus Cadila's COVID-19 vaccine for children, said Dr VK Paul, Member-Health, Niti Aayog on Friday.

The next 100-125 days are critical in the fight against COVID-19, the government said on Friday. The fall in Covid cases after the peak of the second deadly wave two months ago has slowed down, and this should be taken as a warning sign.

Union Health Ministry in its weekly press conference on Friday cautioned that the next 100 to 125 days are critical in the fight against COVID-19 in India.

Four cases of monkeypox have been reported in India but there is absolutely no need for any panic as the government has taken significant measures to keep the disease in check, said Niti Aayog member Dr VK Paul.

Dr VK Paul, Member-Health, Niti Aayog on Thursday said that the overall COVID-19 situation in the country is optimistic, however, India cannot lower its guard.

There will be no mix-and-match of vaccines for those eligible to get a 'precautionary' third dose, Dr VK Paul, the head of India's Covid task force, said Wednesday, meaning those who got Covishield will get the same, as will those who got Covaxin.

The requirement, timing and nature of COVID vaccine booster doses will be based on scientific decisions according to Dr VK Paul, Member-Health, Niti Aayog, today.

Amid concerns over the Omicron variant of coronavirus, Covid Task Force chief Dr VK Paul on Tuesday said India should have vaccine platforms that are "adaptable quickly" with changing nature of the variants.

The Centres priority is to fully vaccinate the adult population of the country against coronavirus, NITI Aayogs Member-Health Dr VK Paul said as the new variant Omicron has triggered a global alarm with several countries imposing fresh curbs.

The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.

The World Health Organisation's approval for emergency use of Covaxin can come before the end of the month, Dr VK Paul, chairman of the National Expert Committee on Vaccine Administration, told reporters today.

Dr VK Paul, the NITI Aayog Member for Health, said battling Covid will require a combination of vaccines, effective drugs, and disciplined social behaviour. He did not ruling out a third wave and cautioned against the risky festival lying ahead.

The national expert committee on COVID-19 vaccination has discussed the issue of giving booster vaccine dose and it is being looked into very deeply, NITI Aayog Member (Health) Dr VK Paul said on Tuesday.

Serosurveys cannot be extrapolated to estimate mortality rates of COVID-19 or undercounting of the number of coronavirus infections as they are not meant to cover granularity at the level of the state, NITI Aayog member (health) Dr VK Paul has said.

The Government of India is holding discussions with COVID-19 manufacturers Moderna and Pfizer over several issues including indemnity waiver, Dr VK Paul, Member (Health), NITI Aayog said on Friday.

Drugs Controller General of India (DCGI) is examining pharmaceutical major Zydus Cadila's COVID-19 vaccine for children, said Dr VK Paul, Member-Health, Niti Aayog on Friday.

The next 100-125 days are critical in the fight against COVID-19, the government said on Friday. The fall in Covid cases after the peak of the second deadly wave two months ago has slowed down, and this should be taken as a warning sign.

Union Health Ministry in its weekly press conference on Friday cautioned that the next 100 to 125 days are critical in the fight against COVID-19 in India.